Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery

Faria, Debora A S; Silva, Edina M K da; Atallah, Álvaro Nagib; Vital, Flávia Mr

doi:10.1002/14651858.cd009134.pub2

Cited by 47 publications

(33 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This conclusion is in line with a Cochrane systematic review [22] of noninvasive respiratory support techniques in acute respiratory failure after upper abdominal surgery that also reported reduced complication rates with CPAP or NIPPV, compared with COT. The complications noted were pneumonia [relative risk (RR) 0.19, 95% CI 0.04-0.88, P = 0.02), sepsis (RR 0.22, 95% CI 0.04-0.99, P = 0.03) and infection (RR 0.27, 95% CI 0.07-0.94; P = 0.03).…”

Section: Reducing the Risk Of Pneumonia And Its Associated Complicatisupporting

confidence: 87%

“…Noninvasive ventilation with high pressures has traditionally been contraindicated after major gastric and oesophageal surgery due to the theoretical risk of gastric dilatation and disruption of surgical anastomoses. Faria et al [22] reported that NIPPV may be considered in patients with acute respiratory failure after oesophageal surgery, when the insufflation pressure level was less than 12 cmH 2 O and air leaks were absent. However, this statement was based on only three prospective studies [12,20,51].…”

Section: Future Research Should Address Several Gapsmentioning

confidence: 99%

See 1 more Smart Citation

Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline

et al. 2020

View full text Add to dashboard Cite

Hypoxaemia is a potential life-threatening yet common complication in the peri-operative and periprocedural patient (e.g. during an invasive procedure at risk of deterioration of gas exchange, such as bronchoscopy). The European Society of Anaesthesiology (ESA) and the European Society of Intensive Care Medicine (ESICM) developed guidelines for the use of noninvasive respiratory support techniques in the hypoxaemic patient in the peri-operative and periprocedural period. The panel outlined five clinical questions regarding treatment with noninvasive respiratory support techniques [conventional oxygen therapy (COT), high flow nasal cannula, noninvasive positive pressure ventilation (NIPPV) and continuous positive airway pressure (CPAP)] for hypoxaemic patients with acute peri-operative/periprocedural respiratory failure. The goal was to assess the available literature on the various noninvasive respiratory support techniques, specifically studies that included adult participants with hypoxaemia in the peri-operative/periprocedural period. The literature search strategy was developed by a Cochrane Anaesthesia and Intensive Care trial search specialist in close collaboration with the panel members and the ESA group methodologist. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the level of evidence and to grade recommendations. The final process was then validated by both ESA and ESICM scientific committees. Among 19 recommendations, the two grade 1B recommendations state that: in the peri-operative/periprocedural hypoxaemic patient, the use of either NIPPV or CPAP (based on local expertise) is preferred to COT for improvement of oxygenation; and that the panel suggests using NIPPV or CPAP immediately post-extubation for hypoxaemic patients at risk of developing acute respiratory failure after abdominal surgery.

show abstract

Section: Reducing the Risk Of Pneumonia And Its Associated Complicatisupporting

confidence: 87%

Section: Future Research Should Address Several Gapsmentioning

confidence: 99%

Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline

et al. 2020

View full text Add to dashboard Cite

show abstract

“…We estimated that with a sample of 150 patients per group evaluated for the primary efficacy outcome, the study had at least 90% power to determine superiority of noninvasive ventilation compared with standard oxygen therapy. For the intention-to-treat analysis, the following assumptions were made: a 65% event rate in the standard oxygen therapy group 10,26,27 and a 40% event rate in the noninvasive ventilation group 14,28,29 (absolute risk reduction with NIV of at least 25% based on expert opinion). Further assumptions (15% of included patients) were made relating to patients randomized despite not being eligible for randomization according to inclusion/exclusion criteria and loss to follow-up for the primary end point.…”

Section: Discussionmentioning

confidence: 99%

“…13 To our knowledge, no multicenter randomized clinical trials have evaluated whether NIV could reduce the need for invasive mechanical ventilation and its effect on the incidence of health care-associated infections in patients who develop hypoxemic acute respiratory failure after abdominal surgery. 14,15 We hypothesized that application of NIV may prevent reintubation and invasive mechanical ventilation and may decrease the rate of health care-associated infections.…”

mentioning

confidence: 99%

Effect of Noninvasive Ventilation on Tracheal Reintubation Among Patients With Hypoxemic Respiratory Failure Following Abdominal Surgery

Jaber

Lescot

Futier

et al. 2016

JAMA

194

127

View full text Add to dashboard Cite

“…As patients began to be admitted, there was very little evidence on the effectiveness of CPAP in Acute Respiratory Failure (ARF) (Williams et al 2013;Bakke et al 2014;Faria et al 2015).…”

Section: Introductionmentioning

confidence: 99%

Early CPAP reduced mortality in covid-19 patients. Audit results from Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust

Ashish

Unsworth

Martindale

et al. 2020

Preprint

View full text Add to dashboard Cite

COVID-19 infection typically causes pneumonia with bilateral changes on Chest radiograph. There is significant hypoxia and use of oxygen for patients admitted to hospital is standard. The use of Continuous Positive Airway Pressure (CPAP) in patients with COVID-19 has now become established as a common clinical practice based on recent experience. It is given as part of best endeavours treatment in the absence of sufficient evidence to guide best practice. The use of CPAP as a step up in clinical care is now common but has a poor evidence base. Using routinely collected data, the use of CPAP as a supportive non-invasive ventilatory treatment is described in 35 patients with COVID infection. Patients given early CPAP and in particular within 48 hours of admission, are shown to have a better outcome (a significant probability of lower mortality) than patients who received late CPAP (more than 48 hours after admission). Although the analysis is affected by a small sample size, the results have shown good evidence that supports the early use of CPAP in patients with COVID-19 infection.

show abstract

Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery

Cited by 47 publications

References 52 publications

Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline

Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline

Effect of Noninvasive Ventilation on Tracheal Reintubation Among Patients With Hypoxemic Respiratory Failure Following Abdominal Surgery

Early CPAP reduced mortality in covid-19 patients. Audit results from Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust

Contact Info

Product

Resources

About